Infectious Disease

Studies of the SARS-CoV-2 genome have indicated one of the main strains is more infectious than others, but it isn’t clear why it is becoming dominant 

Pharmacies are being encouraged to contact their DHB to see how they can participate in a $40 million measles vaccination catch-up scheme announced by the Government today

In the post-lockdown world, there’s still plenty to be done in community pharmacy to control res­piratory infections to keep staff and other patients well, writes infectious disease specialist Richard Everts 

A vaccine against COVID-19 is urgently needed if we’re to stop the virus spreading and prevent potentially millions of further deaths. We’re now one step closer to that goal

The experimental COVID-19 decoy drug made by New Zealand researchers has been found in laboratory tests to slash the coronavirus’ infectivity 

New Zealand moved to Alert Level 2 on 14 May, but for the majority of ­pharmacies not much changed.  

Fiona Cassie wanted to know what happens to the thousands of nasal swabs that are sent away for analysis each day. The Southern Community Laboratories experts who answered her questions are clinical microbiologist Arlo Upton, molecular pathology department head Jenny Grant and clinical microbiologist James Ussher 

New Zealand moved to Alert Level 2 nearly a week ago, but for the majority of pharmacies not much has changed.  

A New Zealand test that provides a COVID-19 result within an hour has received a funding boost 

Influenza has struck few New Zealanders this season, at a time when hundreds are normally enduring the illness